Remimazolam Tosilate
2025-R031
Unknown small_molecule completed
Quick answer
Remimazolam Tosilate for Frailty is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Frailty
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed